001     140511
005     20240321220825.0
024 7 _ |a 10.1016/j.neurobiolaging.2018.11.022
|2 doi
024 7 _ |a pmid:30616208
|2 pmid
024 7 _ |a pmc:PMC6572755
|2 pmc
024 7 _ |a 0197-4580
|2 ISSN
024 7 _ |a 1558-1497
|2 ISSN
024 7 _ |a altmetric:52349038
|2 altmetric
037 _ _ |a DZNE-2020-06833
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Vöglein, Jonathan
|0 P:(DE-2719)2811820
|b 0
|e First author
|u dzne
245 _ _ |a Seizures as an early symptom of autosomal dominant Alzheimer's disease.
260 _ _ |a Amsterdam [u.a.]
|c 2019
|b Elsevier Science
264 _ 1 |3 print
|2 Crossref
|b Elsevier BV
|c 2019-04-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1707492936_2407
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Our objective was to assess the reported history of seizures in cognitively asymptomatic mutation carriers for autosomal dominant Alzheimer's disease (ADAD) and the predictive value of seizures for mutation carrier status in cognitively asymptomatic first-degree relatives of ADAD patients. Seizure occurrence in the Dominantly Inherited Alzheimer Network observational study was correlated with mutation carrier status in cognitively asymptomatic subjects. Of 276 cognitively asymptomatic individuals, 11 (4%) had experienced seizures, and nine of these carried an ADAD mutation. Thus, in the Dominantly Inherited Alzheimer Network population, seizure frequency in mutation carriers was significantly higher than in noncarriers (p = 0.04), and the positive predictive value of seizures for the presence of a pathogenic mutation was 81.8%. Among cognitively asymptomatic ADAD family members, the occurrence of seizures increases the a priori risk of 50% mutation-positive status to about 80%. This finding suggests that ADAD mutations increase the risk of seizures.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
536 _ _ |a 342 - Disease Mechanisms and Model Systems (POF3-342)
|0 G:(DE-HGF)POF3-342
|c POF3-342
|f POF III
|x 1
542 _ _ |i 2019-04-01
|2 Crossref
|u https://www.elsevier.com/tdm/userlicense/1.0/
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Alzheimer Disease: complications
|2 MeSH
650 _ 2 |a Alzheimer Disease: genetics
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Genes, Dominant: genetics
|2 MeSH
650 _ 2 |a Genetic Association Studies
|2 MeSH
650 _ 2 |a Heterozygote
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Mutation: genetics
|2 MeSH
650 _ 2 |a Observational Studies as Topic
|2 MeSH
650 _ 2 |a Predictive Value of Tests
|2 MeSH
650 _ 2 |a Risk
|2 MeSH
650 _ 2 |a Seizures: etiology
|2 MeSH
650 _ 2 |a Seizures: genetics
|2 MeSH
700 1 _ |a Noachtar, Soheyl
|b 1
700 1 _ |a McDade, Eric
|b 2
700 1 _ |a Quaid, Kimberly A
|b 3
700 1 _ |a Salloway, Stephen
|b 4
700 1 _ |a Ghetti, Bernardino
|b 5
700 1 _ |a Noble, James
|b 6
700 1 _ |a Berman, Sarah
|b 7
700 1 _ |a Chhatwal, Jasmeer
|b 8
700 1 _ |a Mori, Hiroshi
|b 9
700 1 _ |a Fox, Nick
|b 10
700 1 _ |a Allegri, Ricardo
|b 11
700 1 _ |a Masters, Colin L
|b 12
700 1 _ |a Buckles, Virginia
|b 13
700 1 _ |a Ringman, John M
|b 14
700 1 _ |a Rossor, Martin
|b 15
700 1 _ |a Schofield, Peter R
|b 16
700 1 _ |a Sperling, Reisa
|b 17
700 1 _ |a Jucker, Mathias
|0 P:(DE-2719)2000010
|b 18
|u dzne
700 1 _ |a Laske, Christoph
|0 P:(DE-2719)2000055
|b 19
|u dzne
700 1 _ |a Paumier, Katrina
|b 20
700 1 _ |a Morris, John C
|b 21
700 1 _ |a Bateman, Randall J
|b 22
700 1 _ |a Levin, Johannes
|0 P:(DE-2719)2811659
|b 23
|u dzne
700 1 _ |a Danek, Adrian
|0 P:(DE-2719)2810712
|b 24
|e Last author
|u dzne
700 1 _ |a Network, Dominantly Inherited Alzheimer
|b 25
773 1 8 |a 10.1016/j.neurobiolaging.2018.11.022
|b : Elsevier BV, 2019-04-01
|p 18-23
|3 journal-article
|2 Crossref
|t Neurobiology of Aging
|v 76
|y 2019
|x 0197-4580
773 _ _ |a 10.1016/j.neurobiolaging.2018.11.022
|g Vol. 76, p. 18 - 23
|0 PERI:(DE-600)1498414-3
|q 76<18 - 23
|p 18-23
|t Neurobiology of aging
|v 76
|y 2019
|x 0197-4580
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572755
856 4 _ |u https://pub.dzne.de/record/140511/files/DZNE-2020-06833_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/140511/files/DZNE-2020-06833_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:140511
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2811820
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 18
|6 P:(DE-2719)2000010
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 19
|6 P:(DE-2719)2000055
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 23
|6 P:(DE-2719)2811659
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 24
|6 P:(DE-2719)2810712
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-342
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms and Model Systems
|x 1
914 1 _ |y 2019
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2022-11-10
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NEUROBIOL AGING : 2021
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-10
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-10
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b NEUROBIOL AGING : 2021
|d 2022-11-10
920 1 _ |0 I:(DE-2719)1110002
|k AG Höglinger 1
|l Translational Neurodegeneration
|x 0
920 1 _ |0 I:(DE-2719)1210001
|k AG Jucker
|l Cell Biology of Neurological Diseases
|x 1
920 1 _ |0 I:(DE-2719)1111016
|k AG Levin
|l Clinical Neurodegeneration
|x 2
920 1 _ |0 I:(DE-2719)7000003
|k U Clinical Researchers - München
|l U Clinical Researchers - München
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1110002
980 _ _ |a I:(DE-2719)1210001
980 _ _ |a I:(DE-2719)1111016
980 _ _ |a I:(DE-2719)7000003
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21